Our Executive Committee

CEO Vasant (Vas) Narasimhan (Photo)

Vasant (Vas) Narasimhan, M.D.

Chief Executive Officer

American

Chief People & Organization Officer Steven Baert (Photo)

Steven Baert

Chief People & Organization Officer

Belgian

Chief Digital Officer Bertrand Bodson (Photo)

Bertrand Bodson

Chief Digital Officer

Belgian

President of NIBR James (Jay) Bradner (Photo)

James (Jay) Bradner, M.D.

President of the Novartis Institutes for BioMedical Research (NIBR)

American

Chief Financial Officer Harry Kirsch (Photo)

Harry Kirsch

Chief Financial Officer

German/Swiss

Group General Counsel Shannon Thyme Klinger (Photo)

Shannon Thyme Klinger

Group General Counsel

American

Global Head of Novartis Technical Operations Steffen Lang (Photo)

Steffen Lang, Ph.D.

Global Head of Novartis Technical Operations (NTO)

German/Swiss

Chief Ethics, Risk and Compliance Officer Klaus Moosmayer (Photo)

Klaus Moosmayer, Ph.D.

Chief Ethics, Risk & Compliance Officer

German

CEO Sandoz Richard Saynor (Photo)

Richard Saynor

Chief Executive Officer of Sandoz

British

President Novartis Oncology Susanne Schaffert (Photo)

Susanne Schaffert, Ph.D.

President of Novartis Oncology

German

Head of Global Drug Development and Chief Medical Officer John Tsai (Photo)

John Tsai, M.D.

Head of Global Drug Development and Chief Medical Officer

American

President Novartis Pharmaceuticals Marie-France Tschudin (Photo)

Marie-France Tschudin

President of Novartis Pharmaceuticals

Swiss

Head of NBS Robert Weltevreden (Photo)

Robert Weltevreden

Head of Novartis Business Services (NBS)

Dutch